BenchSci exponentially increases the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence. As the emerging industry standard, BenchSci now powers reagent selection for over 40,000 researchers at more than 4,500 academic institutions and 16 of the top 20 pharmaceutical companies.